Spikevax receives full TGA registration

Moderna’s Spikevax (elasomeran) has become the first Covid-19 vaccine to receive full registration in Australia  Moderna’s application to transition Spikevax from provisional to full registration was approved by the Therapeutic Goods Administration (TGA) on 21 April.   The regulator said the decision to grant the vaccine full registration was made after a review of long-term